Virus-Like Particle Characterization by SECMALS Using a GTxResolve Premier SEC 1000 Å 3 μm Column

Significance of the Topic

Virus-like particles (VLPs) have emerged as a versatile platform for vaccine development and therapeutic delivery. Their noninfectious nature and ability to present conformational antigens make them critical in immunogenicity studies, quality control, and regulatory compliance during vaccine production and release testing.

Objectives and Overview of Study

This work evaluates the performance of the Waters GTxResolve Premier SEC 1000 Å 3 µm column for characterizing a bacteriophage Qβ-derived VLP. By comparing it against a competing 2.7 µm, 1000 Å SEC column, the study aims to determine purity, aggregation state, and biophysical attributes (molar mass, size) via SEC coupled to multi-angle light scattering (MALS), UV, and refractive index (RI) detectors.

Methodology and Instrumentation

The mobile phase consisted of 1× or 2× Dulbecco’s PBS, filtered through 0.1 µm. Samples of Qβ VLP (2 mg/mL) and bovine thyroglobulin reference (5 mg/mL) were injected (20–50 µL) onto 4.6 × 300 mm columns. Separation was performed at 30 °C with flow rates of 0.4 mL/min and a low-flow variant (0.1 mL/min). Instrumentation included:

• GTxResolve Premier SEC 1000 Å, 3 µm column with MaxPeak HPS hardware
• DAWN MALS detector with WyattQELS module
• Arc Premier 2489 UV/Vis detector (260/280 nm)
• Optilab dRI detector
• ASTRA 8 software for data acquisition and analysis

Main Results and Discussion

UV chromatograms revealed four distinct peaks corresponding to high-order aggregates (Peak 1), dimers (Peak 2), predominant T=3 monomeric capsids and isoforms (Peak 3), and smaller T=1 forms (Peak 4). The GTxResolve column delivered earlier elution, higher aggregate recovery (20.7% vs. 8.2%), and enhanced resolution between Peaks 3 and 4 compared to the competitor column.

SEC-MALS measurements across each peak yielded:

• Peak 1: molar mass 7.1–28.9 MDa; Rg/Rh ~0.97 indicative of extended aggregates
• Peak 2: 4.3–6.0 MDa; Rg/Rh ~0.94 suggesting dimeric and higher oligomeric species
• Peak 3: 2.0–3.4 MDa; Rg/Rh ~0.74 consistent with globular T=3 capsids and proximate isoforms
• Peak 4: 1.4–1.7 MDa correlating with T=1 capsid forms

Lowering the flow rate to 0.1 mL/min further resolved Peak 3 sub-populations and improved separation of Peak 4, underscoring the value of flow-rate optimization for complex samples.

Benefits and Practical Applications

• Robust separation with minimized secondary interactions ensures reproducible recovery of aggregates and monomeric VLPs.
• Accurate molar mass and size determination facilitates quality assessment during process development and release testing.
• Flexible method development through surface-modified packing and adjustable flow rates.

Future Trends and Opportunities

Advances may include higher-throughput SEC-MALS workflows, integration with orthogonal detectors (e.g., charge-detection MS), tailored stationary phases for varied VLP architectures, and automated data analytics for regulatory submissions and real-time quality monitoring.

Conclusion

The GTxResolve Premier SEC 1000 Å 3 µm column outperforms a comparable 2.7 µm column in VLP analysis by delivering higher aggregate recovery, superior resolution, and reliable biophysical characterization. Method optimization, particularly flow-rate tuning, further enhances separation of closely sized VLP isoforms, streamlining decision-making in vaccine and therapeutic development.

Reference

1. Kheirvari M. et al. Virus-like Particle Vaccines and Platforms for Vaccine Development. Viruses. 2023;15:1109.
2. Camacho K.J. et al. Bridged Ethylene Polyethylene Oxide Surfaces to Improve Packing Materials for Widepore SEC. J. Sep. Sci. 2024;47(20).
3. Finny A.S. et al. Enhancing SEC of Large Biomolecular Analytes with GTxResolve™ Premier SEC 1000 Å 3 µm Columns. Waters Corp. 2024.
4. Chang J.-Y. et al. Structural Assembly of Qβ Virion and Its Diverse Forms of VLPs. Viruses. 2022;14:225.
5. Wyatt P.J. Light Scattering and the Absolute Characterization of Macromolecules. Anal. Chim. Acta. 1993;272:1–40.